CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

BSE 524715 SUNPHARMA INE044A01036
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 50NIFTY 500

Filing rhythm · 30 trading days

17 filings · 6 material · busiest 2026-07-31

What it files

General6 Press Release3 Analyst / Investor Meet2 Postal Ballot1 Concall Transcript1 Credit Rating1 Results1 AGM / EGM1

Filings

17 in the window

  1. 25 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst/Institutional Investor Meeting

    Company Update / Analyst / Investor Meet View filing →

  2. 25 August 2026

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    Notice of Postal Ballot/E-voting

    AGM/EGM / Postal Ballot View filing →

  3. 17 August 2026

    General

    Update On Lipitor Antitrust Litigation

    Update on Lipitor Antitrust Litigation

    Company Update / General View filing →

  4. 6 August 2026

    Concall Transcript

    Earnings Call Transcript

    Q1FY27 Earnings Call Transcript

    Company Update / Earnings Call Transcript View filing →

  5. 6 August 2026

    General

    Receipt Of No-Objection Letters From The Stock Exchanges For Reclassification Of Promoter Group

    Receipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group

    Company Update / General View filing →

  6. 5 August 2026

    Credit Rating

    Credit Rating

    Update on Credit Rating

    Company Update / Credit Rating View filing →

  7. 5 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst/Institutional Investor Meeting

    Company Update / Analyst / Investor Meet View filing →

  8. 31 July 2026

    Results

    Unaudited Standalone And Consolidated Financial Results For Q1 Of FY 2026-27

    Quarterly Financial Results for Q1 of FY 2026-27

    Result / Financial Results View filing →

  9. 31 July 2026

    General

    Conclusion Of The Board Meeting Held Today, I.E., 31 July 2026

    Conclusion of the Board Meeting held today

    Company Update / General View filing →

  10. 31 July 2026

    General

    Q1FY27-Investor Call Audio Recording

    SPIL Q1FY27-Investor Call Audio Recording

    Company Update / General View filing →

  11. 31 July 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of the 34th Annual General Meeting held on 31 July 2026

    AGM/EGM / AGM View filing →

  12. 31 July 2026

    General

    Voting Results And Scrutinizer Report Of 34Th AGM Held On 31 July 2026

    Voting Results for 34th AGM

    Company Update / General View filing →

  13. 29 July 2026

    Press Release

    Press Release / Media Release

    Sun Pharma receives approval to manufacture and market semaglutide in Brazil

    Company Update / Press Release / Media Release View filing →

  14. 28 July 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper advertisement about opening of Special Window, for transfer of physical shares

    Company Update / Newspaper Publication View filing →

  15. 27 July 2026

    General

    Update On Nidlegy

    Update on Nidlegy

    Company Update / General View filing →

  16. 24 July 2026

    Press Release

    Press Release / Media Release

    Sun Pharma notes Organon Shareholder approval for proposed acquisition

    Company Update / Press Release / Media Release View filing →

  17. 15 July 2026

    Press Release

    Press Release / Media Release

    Press Release

    Company Update / Press Release / Media Release View filing →